NEW HONEST AND TRUSTWORTHY
奥沙利铂甘露醇注射液3
奥沙利铂甘露醇注射液2
奥沙利铂甘露醇注射液
  • 奥沙利铂甘露醇注射液3
  • 奥沙利铂甘露醇注射液2
  • 奥沙利铂甘露醇注射液
ENGLISH NAME: Oxaliplatin and Mannitol Injection 
SPECIFICATIONS: 100 ml : Oxaliplatin 50 mg : Mannitol 5.1 g
LICENSE NUMBER: 100 ml : Oxaliplatin 50 mg : Mannitol 5.1 g  H20052531
PRODUCT PACKAGING: Penicillin Bottle; 80 bottle/box
FORMULATION: Injection
STORAGE CONDITION: Shading, Closed, Preservation of the Shade
SHELF LIFE: 18 Months
Description: Oxaliplatin is the third generation of platinum agents, which is a landmark product of platinum anticancer drugs. This product is the first-line drug of the gastrointestinal antitumor. It joined the mannitol as solvent can be directly intravenous drip  without  preparation when large capacity injection dosage use in clinical. Oxaliplatin and Mannitol Injection can significantly reduce the patients with renal toxicity of platinum agents. It is indicated for adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. And for the treatment of advanced colorectal cancer. Its chemical name is [(1R,2R) -cyclohexane -1,2-diamine] (ethanedioato-O,O')platinum(II)

Indications: Oxaliplatin and Mannitol Injection is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.And for the treatment of advanced colorectal cancer.

Adverse reaction: The most common adverse reactions in patients with stage II or III colon cancer receiving adjuvant therapy were peripheral sensory neuropathy, neutropenia, thrombocytopenia, anemia, nausea, increase in transaminases and alkaline phosphatase, diarrhea, emesis, fatigue and stomatitis. aaa
bbb
Copyright2015 Cisen Pharmaceutical Co., Ltd. All rights reserved. 鲁ICP备14017151号   SP Design